Reduced lumbar CSF somatostatin in levels in Alzheimer's disease
Paul L. Wood(Lincoln Memorial University), N.P.V. Nair(McGill University), Serge Gauthier(Texas Instruments (France)), Pierre Étienne(McGill University), Santiago Ramón y Cajal(Instituto de Salud Carlos III), Samarthji Lal(Montreal General Hospital)
Cited by 181
Related Papers
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
|Alzheimer s & Dementia|2016|1.9k
Defeating Alzheimer's disease and other dementias: a priority for European science and society
|The Lancet Neurology|2016|1.7k
Mild cognitive impairment: a concept in evolution
|Journal of Internal Medicine|2014|1.7k
Cortisol levels during human aging predict hippocampal atrophy and memory deficits
|Nature Neuroscience|1998|1.6k
A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer’s disease
|Nature Medicine|2021|365